NCT00304005 2013-07-18VNP40101M in Treating Patients With Richter Syndrome or Refractory or Relapsed Chronic Lymphocytic Leukemia or Other Lymphoproliferative DisordersNational Cancer Institute (NCI)Phase 1/2 Completed35 enrolled